Skip to content
Doseworth

Ranked board

Microdose GLP-1 plans, and what a year of one actually costs

Microdose plans are sold as the affordable entry to this category and they are where the four-week billing cycle is most concentrated: every row on this board is billed every 28 days, so every one of them is charged thirteen times a year rather than twelve. Two of the five will not tell you which molecule you are taking, and they are on the board with that stated, because a tier is not a molecule.

By Marla Whitfield, Pricing Editor

Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.

What gets on this board

Every priced row on a published review here that a company itself labels a microdose or low-dose GLP-1. Rows whose molecule the company never names are included, unlike on our single-compound boards — this board ranks a dosing tier, not a drug, so naming the molecule is not what makes a row belong.

What decides the order

Ranked by true-year cost, cheapest first — the price of one cycle with no commitment, multiplied by the number of times a year it is actually billed. Nothing is pinned, sponsored, or lifted into position.

What the spread looks like

$2,327

Cheapest year

Noom Med — Compounded semaglutide — Microdose GLP-1Rx

$2,587

Dearest year

Noom Med — Compounded GLP-1 — Noom GLP-1Rx Plus Microdose

$260

Between the two

Across 5 priced options from 3 companies

Ranked by what a year actually costs

The advertised column is what the company leads with. The walk-away column is what one cycle costs if you stop after it. The year column is the second of those multiplied by the number of times a year it is genuinely billed — which is thirteen, not twelve, for anyone on a four-week cycle.

Company & compoundAdvertisedWalk-awayTrue yearVisit
Noom Med

Compounded semaglutide — Microdose GLP-1Rx

Checked August 2026

$49$179+$130 on the ad$2,327$179 × 13Visit
Vyvron

Low-dose GLP-1 combinations — microdose

Checked August 2026

$149$179+$30 on the ad$2,327$179 × 13Visit
Remedy Meds

Semaglutide — compounded, microdose

Checked August 2026

FDA letter — marketing
$189$189$2,457$189 × 13Visit
Remedy Meds

Tirzepatide — compounded, microdose

Checked August 2026

FDA letter — marketing
$189$189$2,457$189 × 13Visit
Noom Med

Compounded GLP-1 — Noom GLP-1Rx Plus Microdose

Checked August 2026

$79$199+$120 on the ad$2,587$199 × 13Visit

Every price was read off the company's own page on the date shown beside it. The capture procedure, and the five ways a price gets captured wrong, are on our methodology page.

Key terms

Show definitions
Walk-away price
What one cycle costs at the standing, no-commitment rate — what you pay if you stop after it. Not a prepay tier and not a first-month promotion.
True year
The walk-away price multiplied by the number of times it is actually billed in a year: 12 on a calendar-month cycle, 13 on a four-week cycle.
Advertised price
The figure the company leads with on its own pricing page. It is shown here beside the price you pay rather than instead of it.

What this board does not tell you

Whether you qualify

Coverage varies by state, and several of these companies serve fewer states than they appear to. Each review names the exclusions its company actually discloses.

Whether the care is good

This is a cost ranking and nothing else. We have not assessed anyone's clinical care, and there is no quality score anywhere on this site.

What your insurer pays

Every figure here is a cash price. What a covered drug costs you depends on your own plan's formulary and deductible, and no public source publishes a per-drug copay.

Whether the price will hold

Plans restructure without notice. Every row carries the date it was read so you can see how old the number is before you rely on it.

Frequently asked questions

Why are rows here that our cheapest boards refuse to list?

Because the two boards turn on different facts. A cheapest compounded semaglutide board can only carry a row whose molecule the company actually names — putting an unnamed GLP-1 in a semaglutide price column would assert an identity nobody published. This board ranks a dosing tier, and a company that sells a microdose plan has told you it is a microdose plan whatever is in the vial. Where the molecule is unstated, the row says so.

Is a microdose cheaper than a standard dose at the same company?

At the two companies here that sell both, yes, and by an amount worth checking against the plan you would otherwise buy. What this board does not tell you is whether a lower dose is the right thing for you, which is a clinical question and not a pricing one. Every row links to the review that shows the standard-dose price beside it.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.